JPH11279077A - 筋炎予防治療剤 - Google Patents

筋炎予防治療剤

Info

Publication number
JPH11279077A
JPH11279077A JP10083695A JP8369598A JPH11279077A JP H11279077 A JPH11279077 A JP H11279077A JP 10083695 A JP10083695 A JP 10083695A JP 8369598 A JP8369598 A JP 8369598A JP H11279077 A JPH11279077 A JP H11279077A
Authority
JP
Japan
Prior art keywords
cells
myositis
immunoglobulin
cell
reactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10083695A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11279077A5 (enExample
Inventor
Kenji Kikutani
健二 菊谷
Junko Wada
純子 和田
Tadao Okamoto
忠雄 岡元
Nahoko Shintani
奈保子 新谷
Takashi Nakae
孝 中江
Mamoru Koyama
守 小山
Minori Iwamoto
美能里 岩本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Priority to JP10083695A priority Critical patent/JPH11279077A/ja
Publication of JPH11279077A publication Critical patent/JPH11279077A/ja
Publication of JPH11279077A5 publication Critical patent/JPH11279077A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP10083695A 1998-03-30 1998-03-30 筋炎予防治療剤 Pending JPH11279077A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10083695A JPH11279077A (ja) 1998-03-30 1998-03-30 筋炎予防治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10083695A JPH11279077A (ja) 1998-03-30 1998-03-30 筋炎予防治療剤

Publications (2)

Publication Number Publication Date
JPH11279077A true JPH11279077A (ja) 1999-10-12
JPH11279077A5 JPH11279077A5 (enExample) 2005-10-06

Family

ID=13809641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10083695A Pending JPH11279077A (ja) 1998-03-30 1998-03-30 筋炎予防治療剤

Country Status (1)

Country Link
JP (1) JPH11279077A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7254102B2 (en) 2000-08-14 2007-08-07 Ricoh Company, Ltd. Method for optically recording information according to a strategy and computer-readable recording medium for causing a computer to optically record information according to a strategy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7254102B2 (en) 2000-08-14 2007-08-07 Ricoh Company, Ltd. Method for optically recording information according to a strategy and computer-readable recording medium for causing a computer to optically record information according to a strategy

Similar Documents

Publication Publication Date Title
Becker et al. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate
CN112375149B (zh) Ace2免疫融合蛋白及其应用
WO2007131218A2 (en) Compositions and methods for modulating the immune system
US20080299212A1 (en) Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising Blood Plasma or Serum
CN102258780B (zh) 一种螨变应原冻干疫苗及其制备方法
US20220387617A1 (en) Use of cd200 protein and cd200 fusion protein in preparing a drug for treating psoriasis
EP0259438A1 (en) Methods and materials for treatment of rheumatoid arthritis
WO2025237213A1 (zh) 靶向型免疫耐受性疫苗及其制备方法与用途
US4705685A (en) Methods and materials for treatment of disease states involving immunological factors
PT89573B (pt) Metodo para a reducao de respostas mediadas por imunoglobulina e
JPS6250450B2 (enExample)
CN114099664B (zh) 一种基于Treg细胞外泌体的靶向协同药物体系及其制备方法
US6365192B1 (en) Bioactivating substance
JP2012514013A (ja) 腸の炎症性疾患及び１型糖尿病を治療するためのａｐｌ型ペプチドの使用
Boros et al. Effect of antimacrophage serum on hypersensitivity (Schistosoma mansoni egg) and foreign body (divinyl-benzene copolymer bead) granulomas
CN107982530A (zh) Semaphrin7A抗体在制备用于治疗心肌炎疾病的药物中的应用及其药物
JPS58141785A (ja) 抗腫瘍物質の製法
NO322176B1 (no) Anvendelse av pox inducere omfattende en kombinasjon av henholdsvis flere pox virus og parapox virus for fremstilling av medikamentet for prefinal tumorterapi for a lindre smerte og optimalisere velbefinnende til pasienter.
CN103169966B (zh) 一种治疗系统性红斑狼疮的药物组合物
CN103159851A (zh) 预防和抑制炎症的小分子多肽及其应用
CN105163750B (zh) 长效人重组可溶性肿瘤坏死因子α受体在制备预防和治疗慢性肝病重症肝损伤药物中的用途
CN102920653B (zh) 环-反-4-l-羟脯氨酰-l-丝氨酸注射液及其制备方法
RU2139742C1 (ru) Способ терапии поллиноза
CN103897034A (zh) 一种预防和/或治疗炎症反应的小分子多肽及其应用
Brinkman et al. Ocular antigens VIII: assay of delayed hypersensitivity to corneal epithelium in the rabbit.

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050330

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050526

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20071102

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080527

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081007